The FDA has recently approved the Fluency Plus Endovascular Stent Graft to be marketed. The Fluency Plus Endovascular Stent Graft opens up a new blockage in a previously placed stent on the venous side of the dialysis access circuit. The stent graft is placed inside the stent to re-open it allowing adequate blood to flow and dialysis to take place. For more information, please see: http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm405061.htm
Subscriber Services:
Manage Preferences | Unsubscribe | Help with this service
| Stay Connected: | |||||||||||||
 |  |  |  |  |  | ||||||||
Excellent customer service is important to us. Please take a moment to provide feedback regarding the customer service you have received by taking our Customer Service Survey.
| This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 |  |
